Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

An AI-derived digital pathology-based biomarker to predict the benefit of ADT...

Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA

An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408 ( Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA )

Survival outcomes of unilateral RB based on pathological risk stratification...

Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research...

Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan ( Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )

Cancer nursing in India: Tumour lysis syndrome

Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India

Cancer nursing in India: Tumour lysis syndrome ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )

Cancer nursing in India: Febrile neutropenia

Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India

Cancer nursing in India: Febrile neutropenia ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )

SG in combination with pembro in patients with mUC who progressed after...

Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA

SG in combination with pembro in patients with mUC who progressed after platinum (PLT)-based regimens ( Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA )

NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion

Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA

NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion ( Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA )

Latest developments in mHSPC

Prof Kurt Miller and Prof Laura-Maria Krabbe

Latest developments in mHSPC ( Prof Kurt Miller and Prof Laura-Maria Krabbe )

Evaluating a polygenic hazard score to predict risk of developing metastatic or...

Dr Meghana Pagadala - University of California San Diego, San Diego, USA

Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer ( Dr Meghana Pagadala - University of California San Diego, San Diego, USA )

ASCO GU 2022: The latest in CRPC, including PARP combo data

Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel...

ASCO GU 2022: The latest in CRPC, including PARP combo data ( Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel Merseburger )

Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma...

Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The...

Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis ( Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The Netherlands )

Challenges and perspective of cancer patients during the COVID-19 pandemic and...

Dr Rashad Nawfal - Lebanese University, Beirut, Lebanon

Challenges and perspective of cancer patients during the COVID-19 pandemic and the Lebanese financial crisis ( Dr Rashad Nawfal - Lebanese University, Beirut, Lebanon )

Tailoring radiation therapy in the 21st century

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Tailoring radiation therapy in the 21st century ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

More from ecancer